Publications in the Year: 2023

Journal Article

El-Sayed RM, Fawzy MN, Zaki HF, El-Haleim EAA.  2023.  Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: Targeting NLRP3 inflammasome/TXNIP pathway and autophagy modulation. International Immunopharmacology. 115:109711.
Abdel-Kareem NM, Elshazly SM, Galal M, El-Haleim EAA.  2023.  Challenges and Opportunities in Insulin Resistance-induced Cognitive Dysfunction. BULLETIN OF FACULTY OF PHARMACY, CAIRO UNIVERSITY. 61(1):46-56.
Wadie W, Mohamed SS, El-Haleim EAA, Khayyal MT.  2023.  Niacin modulates depressive-like behavior in experimental colitis through GPR109A-dependent mechanisms. Life Sciences. 230:122004.
Elhefnawy EA, Zaki HF, Maraghy NEN, Ahmed KA, El-Haleim EAA.  2023.  Genistein and/or sulfasalazine ameliorate acetic acid-induced ulcerative colitis in rats via modulating INF-γ/JAK1/STAT1/IRF-1, TLR-4/NF-κB/IL-6, and JAK2/STAT3/COX-2 crosstalk. Biochemical Pharmacology. 214:115673.
Tourism